Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9PK92

Entry ID Method Resolution Chain Position Source
AF-Q9PK92-F1 Predicted AlphaFoldDB

No variants for Q9PK92

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q9PK92

No associated diseases with Q9PK92

3 regional properties for Q9PK92

Type Name Position InterPro Accession
domain Protein kinase domain 4 - 296 IPR000719
active_site Serine/threonine-protein kinase, active site 134 - 146 IPR008271
binding_site Protein kinase, ATP binding site 10 - 33 IPR017441

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
protein serine/threonine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

1 GO annotations of biological process

Name Definition
protein phosphorylation The process of introducing a phosphate group on to a protein.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MQRYELIRLI GRGGMGEVYL AHDKACSRRV ALKKIREDLS DNPLLRKRFL REAKIAADLI
70 80 90 100 110 120
HPGIVPVYSI CSDGESVYYT MPYIEGFSLK HLLKSVWQKE ILSKELEEKT SVKAFLPIFD
130 140 150 160 170 180
KICATVEYIH SKGVLHRDLK PDNILLGLFG EVVIVDWGAA IFKHAKELQQ EKDEEGFSSY
190 200 210 220 230 240
GQKNICYSSM TVPGKIVGTP DYMAPESLLG AEASEKTDIY ALGLILYQML TLSFPYRRKK
250 260 270 280 290 300
GRKLPYEDSI LSPIEMAPYR EIPPSLSQIA MKAIAVDPVQ RFSSVQELRK ALQPHLQGES
310 320 330 340 350 360
EWTTRDILST KDRKNWKYYE PILLSRYFPV LASSPAQWYN FMLSDMEVNS SVRVECSVTK
370 380 390 400 410 420
SSVQEGVGIF FPPSKEADKG EFYCGYGLWF SSQNNELSVS LIKNGIEIQK ESQGIIPQQS
430 440 450 460 470 480
RFAISIEKSN NKITVFVDQI LFILHIDYLP SLGERIEIII QDLQGISNIT ILESIGALRV
490 500 510 520 530 540
SCLAVPDAFL AEKLYDQAAR FYRKIRDSFP GRKESYEAQF RLGVTLLTQI EEQGGDLMQA
550 560 570 580 590 600
LSTFDLLHGS TGAPLEYLGK ALVYQRNGSF VEEIRSLLLA LKRYPQHPEI PRLKDHLCFR
610 620 630 640 650 660
LYDSLHKHRS EALVFMLLIL WIAPEKIGLR EEERFLEFLH HRQQSTLFCR IDKTPLQFKS
670 680 690 700 710 720
SKMELFLSFW TGFTLFLPEL FQRARDLRDY QALIDIFYVV CASGNKEVFS QFAEDLAIFV
730 740 750 760 770 780
DEVVFPKSLH NQRGEELVLF VQGLAALQNR EYRQAKEFIS AVPFALQLYA LDLFSLQAFI
790 800 810 820 830 840
DEEVKVFSDF LQDIYNSASA EDHKHVLVYM IQVSLWNQDL KQAYELLSKN FPQDKGLIEY
850 860 870 880 890 900
SEAFVLWGCY LALTGDRSAV KAHFSRCQFK YGRSALIGKC IDDDSLDYLE GLVWWEKKKT
910 920 930
LFQSYFLLRC LHAPKERYEV YRQAYISMEN SFFG